Reduced fluid intake and gastrointestinal adverse effects due to GLP-1 RAs are potential triggers of acute kidney injury (Filippatos et al., 2014; Long et al., 2024), all of which contribute to the significant number of severe outcomes of dehydration following GLP-1 RA use. This evidence concerns the gene GLP1R and acute kidney injury.